» Articles » PMID: 35949508

Myocardin-related Transcription Factor's Interaction with Serum-response Factor is Critical for Outgrowth Initiation, Progression, and Metastatic Colonization of Breast Cancer Cells

Overview
Journal FASEB Bioadv
Specialty Biology
Date 2022 Aug 11
PMID 35949508
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer (BC)-related mortality primarily results from metastatic colonization of disseminated cells. Actin polymerization plays an important role in driving post-extravasation metastatic outgrowth of tumor cells. This study examines the role of myocardin-related transcription factor (MRTF)/serum-response (SRF), a transcription system well known for regulation of cytoskeletal genes, in metastatic colonization of BC cells. We demonstrated that co-depletion of MRTF isoforms (MRTF-A and MRTF-B) dramatically impairs single-cell outgrowth ability of BC cells as well as retards growth progression of pre-established BC cell colonies in three-dimensional (3D) cultures. Conversely, overexpression of MRTF-A promotes initiation and progression of tumor-cell outgrowth in vitro primary tumor formation, and metastatic outgrowth of seeded BC cells in vivo and these changes can be dramatically blocked by molecular disruption of MRTF-A's interaction with SRF. Correlated with the outgrowth phenotypes, we further demonstrate MRTF's ability to augment the intrinsic cellular ability to polymerize actin and formation of F-actin-based protrusive structures requiring SRF's interaction. Pharmacological proof-of-concept studies show that small molecules capable of interfering with MRTF/SRF signaling robustly suppresses single-cell outgrowth and progression of pre-established outgrowth of BC cells in vitro as well as experimental metastatic burden of BC cells in vivo. Based on these data, we conclude that MRTF activity potentiates metastatic colonization of BC cells and therefore, targeting MRTF may be a promising strategy to diminish metastatic burden in BC.

Citing Articles

Breast cancer cells promote osteoclast differentiation in an MRTF-dependent paracrine manner.

Chawla P, Sharma I, Gau D, Eder I, Chen F, Yu V Mol Biol Cell. 2024; 36(1):ar8.

PMID: 39630611 PMC: 11742114. DOI: 10.1091/mbc.E24-06-0285.


Identification of the MRTFA/SRF pathway as a critical regulator of quiescence in cancer.

Panesso-Gomez S, Cole A, Wield A, Anyaeche V, Shah J, Jiang Q bioRxiv. 2024; .

PMID: 39605642 PMC: 11601311. DOI: 10.1101/2024.11.15.623825.


New insights into the pharmacological inhibition of SRF activity: Key inhibitory targets and mechanisms.

Wong D, Qiu H Vascul Pharmacol. 2024; 157():107443.

PMID: 39586415 PMC: 11648470. DOI: 10.1016/j.vph.2024.107443.


mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration.

Eder I, Yu V, Antonello J, Chen F, Gau D, Chawla P Mol Biol Cell. 2024; 35(10):ar133.

PMID: 39196658 PMC: 11481706. DOI: 10.1091/mbc.E24-01-0008.


Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation.

Foda B, Neubig R Int J Mol Sci. 2023; 24(18).

PMID: 37762086 PMC: 10531039. DOI: 10.3390/ijms241813785.


References
1.
Shibue T, Weinberg R . Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci U S A. 2009; 106(25):10290-5. PMC: 2700942. DOI: 10.1073/pnas.0904227106. View

2.
Barkan D, Green J . An in vitro system to study tumor dormancy and the switch to metastatic growth. J Vis Exp. 2011; (54). PMC: 3211127. DOI: 10.3791/2914. View

3.
Joy M, Gau D, Castellucci N, Prywes R, Roy P . The myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms. J Biol Chem. 2017; 292(28):11777-11791. PMC: 5512072. DOI: 10.1074/jbc.M117.781104. View

4.
Hayashi K, Watanabe B, Nakagawa Y, Minami S, Morita T . RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling. PLoS One. 2014; 9(2):e89016. PMC: 3928398. DOI: 10.1371/journal.pone.0089016. View

5.
Engers R, Gabbert H . Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol. 2001; 126(12):682-92. DOI: 10.1007/s004320000148. View